Literature DB >> 2096993

Progesterone antagonists block the growth of experimental mammary tumors in G0/G1.

H Michna, M Schneider, Y Nishino, M F el Etreby, W L McGuire.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2096993     DOI： 10.1007/bf01806296

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  10 in total

1.  Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry.

Authors:  G M Clark; L G Dressler; M A Owens; G Pounds; T Oldaker; W L McGuire
Journal:  N Engl J Med       Date:  1989-03-09       Impact factor: 91.245

2.  Emerging impact of flow cytometry in predicting recurrence and survival in breast cancer patients.

Authors:  W L McGuire; L G Dressler
Journal:  J Natl Cancer Inst       Date:  1985-09       Impact factor: 13.506

3.  Neoplastic transformation and defective control of cell proliferation and differentiation.

Authors:  J J Wille; P B Maercklein; R E Scott
Journal:  Cancer Res       Date:  1982-12       Impact factor: 12.701

4.  Antitumor activity of the antiprogestins ZK 98.299 and RU 38.486 in hormone dependent rat and mouse mammary tumors: mechanistic studies.

Authors:  H Michna; M R Schneider; Y Nishino; M F el Etreby
Journal:  Breast Cancer Res Treat       Date:  1989-12       Impact factor: 4.872

5.  Antiprogestins, a new form of endocrine therapy for human breast cancer.

Authors:  J G Klijn; F H de Jong; G H Bakker; S W Lamberts; C J Rodenburg; J Alexieva-Figusch
Journal:  Cancer Res       Date:  1989-06-01       Impact factor: 12.701

6.  Evaluation of a modeling system for S-phase estimation in breast cancer by flow cytometry.

Authors:  L G Dressler; L Seamer; M A Owens; G M Clark; W L McGuire
Journal:  Cancer Res       Date:  1987-10-15       Impact factor: 12.701

7.  Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice.

Authors:  N Brünner; D Bronzert; L L Vindeløv; K Rygaard; M Spang-Thomsen; M E Lippman
Journal:  Cancer Res       Date:  1989-03-15       Impact factor: 12.701

8.  The antitumor mechanism of progesterone antagonists is a receptor mediated antiproliferative effect by induction of terminal cell death.

Authors:  H Michna; M R Schneider; Y Nishino; M F el Etreby
Journal:  J Steroid Biochem       Date:  1989       Impact factor: 4.292

9.  Antitumor activity of the progesterone antagonists ZK 98.299 and RU 38.486 in the hormone-dependent MXT mammary tumor model of the mouse and the DMBA- and the MNU-induced mammary tumor models of the rat.

Authors:  M R Schneider; H Michna; Y Nishino; M F el Etreby
Journal:  Eur J Cancer Clin Oncol       Date:  1989-04

10.  Coupling of proadipocyte growth arrest and differentiation. II. A cell cycle model for the physiological control of cell proliferation.

Authors:  R E Scott; B J Hoerl; J J Wille; D L Florine; B R Krawisz; K Yun
Journal:  J Cell Biol       Date:  1982-08       Impact factor: 10.539
  10 in total
  2 in total

1.  The tumour-inhibiting potential of the progesterone antagonist Onapristone in the human mammary carcinoma T61 in nude mice.

Authors:  M R Schneider; H Michna; U F Habenicht; Y Nishino; H J Grill; K Pollow
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas.

Authors:  P A Ellis; A Makris; S A Burton; J Titley; M G Ormerod; J Salter; T J Powles; I E Smith; M Dowsett
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.